When industry lobbyists invoke “competitiveness” to defend forever chemicals, it’s time to ask some hard questions. A newly commissioned EU report argues against PFAS restrictions, claiming they’ll destroy Europe’s economy. But when you look beneath the surface, the whole argument falls apart.
Let me walk you through why this report is fundamentally flawed—and what it reveals about the tactics being used to delay action on toxic chemicals.
Meet the Authors (And Their Track Record)
The European Parliament’s Committee on Industry, Research and Energy commissioned Risk and Policy Analysts (RPA) to assess how PFAS restrictions might affect European competitiveness. Sounds reasonable enough, right?
Here’s the problem: RPA has form. Back in 2004, they produced a report on PFOS for the UK government that was so poorly received, the European Commission’s Scientific Committee on Health and Environmental Risks essentially tore it apart. Their main criticism? The report relied heavily on assessments provided by 3M—the very company producing the chemicals in question. Not exactly the kind of independence you’d hope for.
Fast forward to 2026, and we’re seeing the same pattern emerge.
Three Fatal Flaws in the Analysis
Flaw #1: Treating Six Chemicals Like They’re the Entire PFAS Family
The report focuses almost exclusively on six fluoropolymers, which the authors claim represent 93% of fluoropolymer use in Europe. Even if that’s accurate, fluoropolymers themselves only make up 24-40% of all PFAS on the EU market by volume.
Think about that for a moment. They’re making sweeping conclusions about an entire class of thousands of chemicals based on analysis of six substances that represent less than half the problem. That’s like studying six car models and claiming you understand the entire automotive industry.
Flaw #2: The “No Evidence Means It’s Safe” Fallacy
The report acknowledges that some PFAS like PFOA and PFOS cause cancer and hormone disruption. But for the six fluoropolymers they focused on? The authors claim there’s been “minimal research” into health effects, and therefore assume they’re safe.
This is backwards logic at its finest.
What the report conveniently ignores is that most studies on fluoropolymers only assess the “use phase”—when a consumer is actually using a product. They skip right over the production phase (when chemicals are manufactured) and end-of-life phase (when products are disposed of), which is precisely where the majority of PFAS pollution occurs.
Perhaps that’s why three major chemical companies just settled a lawsuit in the United States over PFAS contamination leaking from their industrial facilities. The pollution doesn’t magically appear—it comes from somewhere.
Flaw #3: Zero Benefits Counted
In conducting their cost-benefit analysis, the authors assigned exactly zero financial value to the health and environmental benefits of restricting these chemicals. Zero. Nothing. Nada.
Their reasoning? Since they’ve already decided (based on incomplete evidence) that these fluoropolymers don’t cause measurable harm, there can’t be any benefit to restricting them.
This completely ignores the European Commission’s own recent estimate that inaction on PFAS will cost society €440 billion. But apparently, that number didn’t make it into the competitiveness calculation.
The Numbers Game: Scary Headlines, Questionable Math
The report claims that an immediate, full PFAS restriction would cost Europe €562.8 billion in the first year. That’s a massive, attention-grabbing number.
But look closer: this appears to be the entire market value of four industrial sectors added together—as if a restriction would cause these entire industries to instantly collapse and every worker to lose their job overnight. That’s not how transitions work, and it’s not what the PFAS restriction proposal suggests.
Even more revealing: when the authors modeled a gradual phase-out over 10+ years (giving companies time to adapt), the estimated cost barely changed—less than 0.2% difference. This makes no sense unless you’ve already decided that adaptation is impossible.
Remember: all these dire cost projections assume zero health or environmental benefits, immediate industry collapse, and 100% unemployment in affected sectors. It’s catastrophizing, not careful economic analysis.
The Solution They’re Selling: Unlimited Exemptions
After painting this apocalyptic picture, the report offers a convenient solution: give certain sectors unlimited exemptions from any PFAS ban. Not temporary derogations to allow time for transition—unlimited exemptions.
This defeats the entire purpose of a restriction. If companies know they’ll never have to change, why would they invest in alternatives? Why would innovation occur? The report essentially recommends freezing the status quo forever.
Ironically, one of the sectors they argue needs these permanent exemptions is “green and clean tech.” Let that sink in: they’re saying environmental technology depends on forever chemicals and should be allowed to use them indefinitely. The contradiction is almost funny—if the stakes weren’t so high.
The Fluorinated Gas Oversight
Despite claiming to consider fluorinated gases (F-gases) in their analysis, the report gives them minimal attention before recommending they be excluded from restrictions entirely.
This is particularly egregious because F-gases are among the largest contributors to PFAS emissions in Europe, especially from refrigeration and heat pumps. They’re also the area where alternatives are most advanced and readily available. The original PFAS restriction dossier explicitly identifies high substitution potential for most F-gas applications.
If you were genuinely trying to find where European industry could transition fastest and most cost-effectively, you’d focus heavily on F-gases. Instead, this report brushes them aside.
Why This Matters Now
In the coming months, the European Chemicals Agency’s Committee for Socio-economic Analysis will publish its own comprehensive assessment on these exact issues. Their analysis will be far more transparent and thorough.
Which raises an obvious question: why release this report now, with such glaring methodological problems? And whose interests does it really serve?
The timing suggests an attempt to seed doubt and create political cover for delaying or weakening restrictions—right before more credible analysis arrives.
The Real Competitiveness Story
Here’s what the report won’t tell you: the narrative that PFAS “enable” competitiveness is self-fulfilling. By granting indefinite exemptions and blocking restrictions, you guarantee that industries remain dependent on these chemicals. You also guarantee that companies investing in safer alternatives are at a competitive disadvantage.
True competitiveness comes from innovation, not chemical dependency. Countries and companies that lead the transition to safer alternatives will have access to markets that increasingly demand PFAS-free products. Those clinging to forever chemicals will find themselves locked out.
The European Union has a choice: it can reward chemical dependency and stifle innovation, or it can set clear timelines that drive investment toward safer solutions. One path leads to short-term profits for a few corporations. The other leads to long-term health, environmental protection, and genuine industrial competitiveness.
The Bottom Line
This report is not serious economic analysis. It’s advocacy dressed up in the language of competitiveness.
The assumptions are flawed. The methodology is questionable. The conclusions conveniently align with industry lobbying positions. And the timing is suspiciously designed to influence policy before more rigorous analysis becomes available.
Europe deserves better than junk science masquerading as economic expertise. The stakes—for public health, environmental protection, and genuine industrial innovation—are simply too high to base policy on a report that wouldn’t pass peer review.
The question isn’t whether Europe can afford to restrict PFAS. Given the €440 billion cost of inaction, the real question is: can we afford not to?
The European Chemicals Agency’s comprehensive socio-economic analysis will be published in the coming months. Unlike this competitiveness report, it will undergo rigorous peer review and transparent methodology. Stay tuned.
